Boston Beer Company, Inc. (The) Common Stock (SAM)
233.27
-5.87 (-2.45%)
Boston Beer Company is a leading craft brewer known for its innovative brewing techniques and a diverse portfolio of alcoholic beverages, including its flagship Samuel Adams beer
The company focuses on producing high-quality, handcrafted beers and has expanded its offerings to include hard seltzers, ciders, and ready-to-drink cocktails, catering to a wide variety of consumer tastes. Through a commitment to brewing excellence and sustainability, Boston Beer Company has become a significant player in the beverage industry, continually seeking to enhance its products while promoting responsible alcohol consumption.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at beverages, alcohol, and tobacco stocks, starting with Vita Coco (NASDAQCOCO).
Let’s dig into the relative performance of MGP Ingredients (NASDAQMGPI) and its peers as we unravel the now-completed Q4 beverages, alcohol, and tobacco earnings season.
Beer company Boston Beer (NYSESAM) reported Q4 CY2024 results exceeding the market’s revenue expectations, with sales up 2.2% year on year to $402.3 million. Its GAAP loss of $3.38 per share was significantly below analysts’ consensus estimates.
Sales growth for Boston Beer Co. in 2025 and 2026 may be slower than expected, according to Piper Sandler due to underperformance of Hard Mountain Dew and Twisted Tea.
Over the last six months, Boston Beer’s shares have sunk to $254.50, producing a disappointing 7.5% loss - a stark contrast to the S&P 500’s 7.7% gain. This may have investors wondering how to approach the situation.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Vita Coco (NASDAQCOCO) and the rest of the beverages, alcohol, and tobacco stocks fared in Q3.
Shares of major alcohol producers and distributors declined sharply following a warning issued by U.S. Surgeon General Vivek Murthy about the increased cancer risks associated with alcohol consumption.
Boston Beer has been treading water for the past six months, recording a small return of 3.4% while holding steady at $313.04. The stock also fell short of the S&P 500’s 14% gain during that period.
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the beverages, alcohol and tobacco stocks, including Coca-Cola (NYSEKO) and its peers.
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how beverages, alcohol and tobacco stocks fared in Q3, starting with Monster (NASDAQMNST).
Looking back on beverages, alcohol and tobacco stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Tilray Brands (NASDAQTLRY) and its peers.
